Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT)

Jácome, Cristina; Pereira, Ana Margarida; Almeida, Rute; Amaral, Rita; Alves‐Correia, Magna; Mendes, Sandra; Vieira‐Marques, Pedro; Ferreira, José Alberto; Lopes, Inês; Gomes, Jancarlo Ferreira; Vidal, Carmen; Freire, Sara López; Méndez‐Brea, Paula; Arrobas, AM; Valério, Margarida; Loureiro, Carla Chaves; Santos, LM; Couto, Mariana; Araújo, Luís; Bom, Ana Todo; Azevedo, João; Cardoso, João; Emiliano, Madalena; Gerardo, Rita; Lozoya, Carlos; Pinto, P L; Neves, Ana Castro; Pinto, Nicole; Palhinha, Ana; Teixeira, F.; Ferreira-Magalhães, Manuel; Alves, Crésio de Aragão Dantas; Coelho, Didina; Santos, Natacha; Menezes, Fernando; Gomes, Ricardo; Rodrigues, JC Cidrais; Oliveira, Georgeta; J, Carvalho; Alves, Rodrigo Rodrigues; Moreira, A S; Costa, Alberto; Abreu, Carmo; Silva, R.; Morête, Ana; Falcão, Helena; Marques, Maria Luís; Câmara, Raquel; Cálix, M J; Bordalo, Diana

doi:10.18176/jiaci.0640

Cited by 10 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We included 16 original studies (published throughout 23 reports) in our systematic review (Table 1). 17–22,34–50 …”

Section: Resultsmentioning

confidence: 99%

“…Table 1 summarises the characteristics of included studies. The original Portuguese version of CARAT was used in 8 studies (11 reports) 17,19,34–39,42,46,47 . There were 2 studies (3 reports) on the Italian, 40,41,45 German and Dutch 18,21,40 versions of CARAT 22,43,44 .…”

Section: Resultsmentioning

confidence: 99%

“…Nevertheless, performing meta‐analyses on the Cronbach's alpha (internal consistency) demonstrated the good internal consistency of CARAT. The COSMIN guidelines recommend the risk of bias to be increased when studies do not report the Cronbach's alpha for its subscales, which was the case for two of the studies included 46,47 . However, CARAT was developed as a global instrument to assess both asthma and AR control, following ARIA's vision that asthma and AR are interdependent conditions which should be managed simultaneously 14 .…”

Section: Discussionmentioning

confidence: 99%

“…We included 16 original studies (published throughout 23 reports) in our systematic review (Table 1). [17][18][19][20][21][22][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50] VIEIRA ET AL.…”

Section: Study Selectionmentioning

confidence: 99%

See 3 more Smart Citations

Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis

Vieira

Sousa‐Pinto

Cardoso-Fernandes

et al. 2022

Clinical & Translational All

View full text Add to dashboard Cite

The Control of Allergic Rhinitis and Asthma Test (CARAT) is a patient‐reported outcome measurement (PROM) assessing the control of asthma and allergic rhinitis (AR) at a 4 week interval. This systematic review aimed to evaluate the measurement properties of CARAT. Following PRISMA and COSMIN guidelines, we searched five bibliographic databases and retrieved studies concerning the development, assessment of properties, validation, and/or cultural adaption of CARAT. The studies' methodological quality, the quality of measurement properties, and the overall quality of evidence were assessed. We performed meta‐analysis of CARAT measurement properties. We included 16 studies. Control of Allergic Rhinitis and Asthma Test displayed sufficient content validity and very good consistency (meta‐analytical Cronbach alpha = 0.83; 95% CI = 0.80–0.86;I2 = 62.6%). Control of allergic rhinitis and Asthma Test meta‐analytical intraclass correlation coefficient was 0.91 (95% CI = 0.64–0.98;I2 = 93.7%). It presented good construct validity, especially for correlations with Patient‐reported outcome measures assessing asthma (absolute Spearman correlation coefficients range = 0.67–0.73; moderate quality of evidence), and good responsiveness. Its minimal important difference is 3.5. Overall, CARAT has good internal consistency, reliability, construct validity and responsiveness, despite the heterogeneous quality of evidence. Control of Allergic Rhinitis and Asthma Test can be used to assess the control of asthma and AR. As first of its kind, this meta‐analysis of CARAT measurement properties sets a stronger level of evidence for asthma and/or AR control questionnaires.

show abstract

“…We included 16 original studies (published throughout 23 reports) in our systematic review (Table 1). 17–22,34–50 …”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Study Selectionmentioning

confidence: 99%

See 2 more Smart Citations

Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis

Vieira

Sousa‐Pinto

Cardoso-Fernandes

et al. 2022

Clinical & Translational All

View full text Add to dashboard Cite

show abstract

“…Technologies of information and communication, namely the telephone, offer a simple and effective alternative to paper-forms to keep monitoring these individuals ( 17 , 19 ). Evidence has shown that telephone administration of some health instruments for symptoms control ( 20 ) and measurement of HRQoL ( 21 , 22 ) is comparable to the in-person application. However, the psychometric properties of specific questionnaires to people with COPD still need to be explored; specifically, the reliability and validity of the telephone administration of the Functional Assessment of Chronic Illness-Fatigue-Subscale (FACIT-FS) and the St. George's Respiratory Questionnaire (SGRQ) have never been tested and only one study assessed these properties in the COPD Assessment Test (CAT) ( 23 ).…”

Section: Introductionmentioning

confidence: 99%

Are in Person and Telephone Interviews Equivalent Modes of Administrating the CAT, the FACIT-FS and the SGRQ in People With COPD?

Rocha

Jácome

Martins

et al. 2021

Front. Rehabilit. Sci.

View full text Add to dashboard Cite

Background: The COVID-19 pandemic brought numerous challenges, namely in routine assessment of people with chronic obstructive pulmonary disease (COPD). The COPD Assessment Test (CAT), the Functional Assessment of Chronic Illness-Fatigue-Subscale (FACIT-FS) and the St. George's respiratory questionnaire (SGRQ) are important patient-reported outcome measures used to assess people with COPD, but its face-to-face application has been compromised. The telephone interview offers a simple and effective alternative, yet uncertainty regarding its equivalence remains. This study aimed to establish the reliability and validity of the CAT, the FACIT-FS and the SGRQ administered by telephone interview in people with COPD.Methods: Data from an observational prospective study including people with COPD were analyzed. Participants answered to the CAT, FACIT-FS and SGRQ questionnaires in person and by telephone, with a maximum interval of 48-h. Participants were randomly selected to answer first to the in-person questionnaire followed by telephone or vice versa. Reliability measures included internal consistency with Cronbach's alpha, test-retest reliability with the intraclass correlation coefficient (ICC2,1), test-retest measurement error with the standard error of measurement (SEM) and agreement with the Bland and Altman 95% limits of agreement. Validity was assessed with the Spearman correlation (rho).Results: Fifty-five people with COPD (44 men; 68.1 ± 7.9 years; FEV1: 59.1 ± 20.3% predicted) were included. Similar internal consistency was observed between in person vs. telephone interview for the CAT (0.82 vs. 0.84), the FACIT-FS (0.83 vs. 0.84) and the SGRQ (0.92 vs. 0.93). Test-retest reliability was excellent, with an ICC2,1 of 0.77 (95% CI: 0.65; 0.86), 0.86 (95% CI: 0.77; 0.92) and 0.94 (95% CI: 0.90; 0.96) for the CAT, FACIT-FS and SGRQ total scores, respectively. The SEM showed a low level of associated measurement error and the Bland and Altman plots illustrated a good level of agreement between both modes of administration, with no evidence of systematic bias. Robust positive correlations (rho 0.87–0.94, p < 0.001) were found for the CAT, FACIT-FS and SGRQ total scores applied by both methods.Conclusion: The telephonic administration of the CAT, the FACIT-FS and the SGRQ are a valid and reliable alternative approach to in person interviews for monitoring symptoms and health-related quality of life in people with COPD. The telephone might be an important add-on for personalized assessment and management of COPD thru remote monitoring.

show abstract

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise

Damask

Roland

et al. 2023

Int Forum Allergy Rhinol

106

View full text Add to dashboard Cite

Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

show abstract

Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT)

Abstract: Supplementary material Supplementary Figure 1. Data collection timeline Supplementary Figure 2. Scatter plot showing the relationship between days between assessments and difference in Control of Allergic Rhinitis and Asthma Test total scores (CARAT-T).

Cited by 10 publications

References 0 publications

Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis

Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis

Are in Person and Telephone Interviews Equivalent Modes of Administrating the CAT, the FACIT-FS and the SGRQ in People With COPD?

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Contact Info

Product

Resources

About